.png)
German (DE) 
English (US) 
Spanish (ES) 
French (FR) 
Hindi (IN) 
Italian (IT) 
Russian (RU) Rameen Kasana
Tue, Jun 17, 2025, 12:30 PM 2 min read
In This Article:
Prothena Corporation plc (NASDAQ:PRTA) is among the best NASDAQ stocks under $50 to buy. Roche, a partner of Prothena Corporation plc (NASDAQ:PRTA), has announced plans to initiate Phase 3 development of prasinezumab for early-stage Parkinson’s disease. Although the company faced a setback with birtamimab, which failed to meet the desired result, the giant is keen on taking things forward with new developments.
This decision comes after the company’s favorable Phase 2b PADOVA results and sustained follow-up data highlighting clinical benefit when prasinezumab solution and symptomatic treatment are used together. This creates exciting opportunities for the company, which has a potential upside of over 300%, as the one-year price target of $24.29 by Yahoo Finance suggests.
A doctor examining the results of a patient's medical scan displayed on a computer monitor.
One thing that is most important for companies such as Prothena Corporation plc (NASDAQ:PRTA) is the determination to stand strong despite failures. The company’s strong pipeline, including Alzheimer’s, Parkinson’s, and ATTR-CM candidates, makes us believe that achieving the upside potential isn’t hard to achieve, particularly when the Alzheimer’s Disease market is anticipated to reach $19.3 billion by 2033.
Prothena Corporation plc (NASDAQ:PRTA) is an Ireland-based late-stage clinical biotechnology company that identifies and develops novel therapies for diseases caused by protein dysregulation. Incorporated in 2012, the company focuses on advancing therapies through clinical development, often in collaboration with other organizations.
While we acknowledge the potential of PRTA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.
Disclosure: None.
Comments